Health Canada says neffy spray could be on the market as soon as this summer.Sean Kilpatrick/The Canadian Press
Health Canada has approved the first needle-free epinephrine treatment for severe allergic reactions: a nasal spray called neffy.
ALK Canada, which purchased the rights to distribute the drug, says the two-milligram treatment has been approved for adults and pediatric patients who weigh at least 30 kilograms – roughly 66 lbs.
It says the spray could be on the market as soon as this summer.
As it stands, epinephrine auto-injectors – known by the brand name EpiPen – are the only emergency treatment option available for allergic reactions.
EpiPens are single-use, pre-filled devices used to shoot a dose of epinephrine into the muscle.
Neffy was approved for use in the United States in summer 2024, where it is also available in a one-milligram dose for kids who weigh 15 to 30 kg. That dose has not been approved in Canada.
Food Allergy Canada is applauding the approval of the two-milligram treatment as “an important step forward” that gives Canadians more choices.





![21st Jun: Strategist KANBE (2014), 50 Episodes [TV-14] (6/10) 21st Jun: Strategist KANBE (2014), 50 Episodes [TV-14] (6/10)](https://occ-0-710-1007.1.nflxso.net/dnm/api/v6/0Qzqdxw-HG1AiOKLWWPsFOUDA2E/AAAABfN2nUCEdbC0QExKKuVWWKM6DMevnydbmZtJ50D-SpzszXqj5DWj4b1XhY1VdJRZrWtTw60hrHW1auReuQJ4aMSIH92lmEmhiwdgoD4SC-11StxXZVZCp1ks6ETRaPnJqhwhOKZqAxZQWgT44t3lUQFPqJZK0yp-yVTGUlv5bWphrA.jpg?r=778)


